Advertisement

Journal of Pharmaceutical Innovation

, Volume 14, Issue 1, pp 57–65 | Cite as

Improve Solubility of Acetamidophenol from PEG and Witepsol Suppositories via Formation of Inclusion Complex by β-Cyclodextrin with a Controlled Release Profile

  • Faezeh Asgari
  • Sahar AmiriEmail author
  • Majid Ghiass
Original Article
  • 51 Downloads

Abstract

Purpose

Acetamidophenol (ACP) is used to treat mild to moderate pain and reduce fever, but low water solubility and poorly dissolution of this compound restricted its bioavailability.

Methods

To overcome these problems and enhance the solubility of ACP, inclusion complex between ACP and β-cyclodextrin (β-CD) is formed with various mass ratios of β-CD:ACP (1:1, 1:2, 1:4, 1:8), and the effect of complex formation on solubility and release of ACP from PEG and Witepsol-based suppositories through rectal route of administration is investigated.

Results

Inclusion complexes formed with various ratios of β-CD:ACP and loaded in the formulation of suppositories by fusion method utilizing different suppository bases, i.e., Witepsol H15 and polyethylene glycol (4000, 400). FTIR, SEM, and XRD results indicate formation of inclusion complex between β-CD and ACP. Physical characteristics and in vitro drug release of the obtained suppositories are determined by several tests such as weight variation, melting point, hardness, and release rate.

Conclusion

Results indicate that PEG-based suppositories containing β-CD:ACP 1:1 mass ratio show the best in vitro drug release characteristic which released 19.3% of ACP after 8 h.

Keywords

Suppository PEG Witepsol Acetamidophenol β-cyclodextrin Controlled release 

References

  1. 1.
    David SJ. Pharmaceutics dosage form and design, 2nd edition, chapter 4; 2016:4–7.Google Scholar
  2. 2.
    Jahromi MM, Ghaemi H, Tafti MA, Arabzadeh A, Afsharypuor S. Vaginal and rectal dosage forms in Iranian traditional pharmacy. J Nat Pharm Prod. 2015;10:1–3.Google Scholar
  3. 3.
    Schrewsbury R. Applied pharmaceutics in contemporary compounding, 3rd edition, 2015.Google Scholar
  4. 4.
    Baviskara P, Bedsea A, Sadiqueb S, Kundea V, Jaiswal S. Drug delivery on rectal absorption: suppositories. Int J Pharm Sci Rev Res. 2013;13:70–6.Google Scholar
  5. 5.
    El-Majri MA, El-Basir MM. Formulation and evaluation of ibuprofen suppositories. J Res Pharm Pract. 2016;7:87–90.Google Scholar
  6. 6.
    Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm. 2000;197:1–11.CrossRefGoogle Scholar
  7. 7.
    Demirel M, Yurtdas G, Genc L. Inclusion complexes of ketoconazole with beta-cyclodextrin: Physicochemical characterization and in vitro dissolution behaviour of its vaginal suppositories. J Incl Phenom Macrocycl Chem. 2011;70:437–45.CrossRefGoogle Scholar
  8. 8.
    Sinha VR, Nanda A, Kumria R. Cyclodextrins as sustained-release carriers. J Pharm Technol 2002:36–46.Google Scholar
  9. 9.
    Allen JR, Loyd V. Quality control of suppositories. Suppositories, 1st edition; 2007:139–158.Google Scholar
  10. 10.
    Yousfan A, Hasian J. Preparation and evaluation of levodropropizine suppositories. J Chem Pharm Res. 2015;7:274–82.Google Scholar
  11. 11.
    Ramadan AA. Formulation and evaluation of bioadhesive vaginal suppositories containing miconazole nitrate. J Pharm Bio Sci. 2013;4:455–72.Google Scholar
  12. 12.
    Pandey S, Varshney HM, Gupta MM. Effect of adjuvants on the release pattern of suppositories containing paracetamol. J Chem Environ Sci. 2013;1:19–25.Google Scholar
  13. 13.
    Amiri S, Rahimi A. Self-healing hybrid nanocomposite coatings containing encapsulated organic corrosion inhibitors nanocontainers. J Polym Res 2014, DOI:  https://doi.org/10.1007/s10965-014-0624-z.
  14. 14.
    Amiri S, Rahimi A. Synthesis and characterization of supramolecular corrosion inhibitor nanocontainers for anticorrosion hybrid nanocomposite coatings. J Polym Res. 2015 DOI:  https://doi.org/10.1007/s10965-015-0699-1
  15. 15.
    Amiri S, Rahimi A. Preparation of supramolecular corrosion inhibitor nanocontainers for self-protective hybrid nanocomposite coatings. J Polym Res 2014, DOI:  https://doi.org/10.1007/s10965-014-0566-5
  16. 16.
    Amiri S, Rahimi A. Anticorrosion behavior of cyclodextrins/inhibitor nanocapsule-based self-healing coatings. J Coat Technol Res. 2016;13:1095–102.  https://doi.org/10.1007/s11998-016-9824-2.CrossRefGoogle Scholar
  17. 17.
    Amiri S, Rahimi A. Self-healing anticorrosion coating containing 2-mercaptobenzothiazole and 2-mercaptobenzimidazole nanocapsules. J Polym Res. 2016;23:23–83.CrossRefGoogle Scholar
  18. 18.
    The United States Pharmacopeia, USP 38, Volume 1, 2015.Google Scholar
  19. 19.
    Cwiertnia B. Effect of water soluble carrier on dissolution profiles of diclofenac sodium. J Pharm Technol. 2013;70:721–6.Google Scholar
  20. 20.
    Gowthamarajan K, Kulkarni TG, Nenkateswaran G, Samanta MK, Suresh B. Formulation and dissolution properties of meloxicam solid dispersion incorporated suppositories. Indian J Pharm Sci. 2002;1:525–8.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Polymer Engineering, Science and Research BranchIslamic Azad UniversityTehranIran
  2. 2.Iran Polymer and Petrochemical Institute, IPPIDepartment of Polymer Science, Faculty of ScienceTehranIran

Personalised recommendations